Researchers in China have achieved a groundbreaking milestone by developing a biological pacemaker from stem cells, representing a significant leap in the study of heart diseases. The team engineered a miniature sinoatrial node that produces consistent electrical signals and linked it with nerve cells to manage heartbeat functions. This laboratory-created system also mimicked irregular heart rhythms, enabling scientists to evaluate treatment effects in a controlled environment. This advancement has the potential to enhance drug safety evaluations and speed up the creation of tailored therapies for heart-related issues. Authorities in the field believe this research could transform future methods for addressing rhythm-related heart diseases globally.
